We are live on
!
Find out more
TC
Tejara Capital Portfolio holdings
AUM
$303M
1-Year Est. Return
5.43%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$272M
AUM Growth
+$33.4M
(+14%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
4.55%
Top 10 Holdings %
Top 10 Hldgs %
48.68%
Holding
93
New
26
Increased
22
Reduced
22
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scorpio Tankers
STNG
|
+$11.8M |
| 2 |
Rekor Systems
REKR
|
+$5.04M |
| 3 |
Roivant Sciences
ROIV
|
+$5.02M |
| 4 |
QuidelOrtho
QDEL
|
+$4.08M |
| 5 |
iShares Silver Trust
SLV
|
+$3.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$9.57M |
| 2 |
Citigroup
C
|
+$7.9M |
| 3 |
Freeport-McMoran
FCX
|
+$5.18M |
| 4 |
Collegium Pharmaceutical
COLL
|
+$4.34M |
| 5 |
MREO
Mereo BioPharma
MREO
|
+$4.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.56% |
| 2 | Energy | 35.34% |
| 3 | Technology | 5.46% |
| 4 | Industrials | 4.42% |
| 5 | Financials | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arbutus Biopharma
ABUS
$847M
| – | – |
-180,077
| Closed | -$450K |
|
77
Agnico Eagle Mines
AEM
$72.2B
| – | – |
-20,500
| Closed | -$1.12M |
|
78
AGNC Investment
AGNC
$12.7B
| – | – |
-110,880
| Closed | -$1.09M |
|
79
ANI Pharmaceuticals
ANIP
$1.86B
| – | – |
-23,000
| Closed | -$1.27M |
|
|
80
Citigroup
C
$213B
| – | – |
-153,621
| Closed | -$7.9M |
|
81
Cameco
CCJ
$36.8B
| – | – |
-10,000
| Closed | -$431K |
|
|
82
Collegium Pharmaceutical
COLL
$1.18B
| – | – |
-141,099
| Closed | -$4.34M |
|
83
Comstock Resources
CRK
$3.7B
| – | – |
-40,700
| Closed | -$360K |
|
|
84
Freeport-McMoran
FCX
$86.2B
| – | – |
-121,700
| Closed | -$5.18M |
|
85
Frontline
FRO
$8.71B
| – | – |
-40,800
| Closed | -$818K |
|
86
Karyopharm Therapeutics
KPTI
$155M
| – | – |
-68,757
| Closed | -$892K |
|
87
Kenvue
KVUE
$38B
| – | – |
-95,000
| Closed | -$2.05M |
|
|
88
Newmont
NEM
$96.2B
| – | – |
-231,300
| Closed | -$9.57M |
|
89
Plains All American Pipeline
PAA
$17.6B
| – | – |
-38,940
| Closed | -$1.56K |
|
90
ARS Pharmaceuticals
SPRY
$579M
| – | – |
-73,739
| Closed | -$404K |
|
91
Sociedad Química y Minera de Chile
SQM
$19.3B
| – | – |
-39,000
| Closed | -$2.35M |
|
|
MAGN
92
Magnera Corp
MAGN
$493M
| – | – |
-13,272
| Closed | -$335K |
|
|
VINC
93
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| – | – |
-11,667
| Closed | -$275K |
|
Similar funds
EC
ECAM
BPH
BCC
BKA
AFO
OWM
WAOTB
Tejara Capital's Q1 2024 Portfolio in Review
As of Q1 2024, Tejara Capital held 93 positions worth $272M, up 14% from $239M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Tejara Capital deployed $12.4M of net new capital in Q1 2024, opening 26 new positions and adding to 22 existing holdings. Its largest new stake was QuidelOrtho: 70,000 shares worth $3.36M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Mereo BioPharma, an estimated $4.21M trimmed.
- Tejara Capital's largest Q1 2024 buy was QuidelOrtho: 70,000 shares worth $3.36M.
- Tejara Capital added most to Scorpio Tankers in Q1 2024, an estimated $11.8M increase.
- Tejara Capital's biggest Q1 2024 reduction was Mereo BioPharma, cutting an estimated $4.21M.
- Tejara Capital fully exited Newmont in Q1 2024, selling an estimated $9.57M.
- Tejara Capital's ten largest holdings make up 49% of its $272M portfolio in Q1 2024.
- Tejara Capital opened 26 new positions and closed 18 in Q1 2024.
- Tejara Capital's portfolio value rose 14% quarter-over-quarter to $272M.
Based on Tejara Capital's 13F filing for Q1 2024, filed 14 May 2024.